SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019445
Filing Date
2021-08-11
Accepted
2021-08-11 16:06:26
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20210630_10q.htm   iXBRL 10-Q 841488
2 EXHIBIT 10.4 ex_269494.htm EX-10.4 24763
3 EXHIBIT 10.5 ex_269495.htm EX-10.5 90503
4 EXHIBIT 31.1 ex_250349.htm EX-31.1 13433
5 EXHIBIT 31.2 ex_250350.htm EX-31.2 13267
6 EXHIBIT 32.1 ex_250351.htm EX-32.1 6599
7 EXHIBIT 32.2 ex_250352.htm EX-32.2 6675
13 moleculinlogoresizedclear.jpg GRAPHIC 19339
  Complete submission text file 0001437749-21-019445.txt   4078213

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20210630.xsd EX-101.SCH 41963
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20210630_cal.xml EX-101.CAL 24890
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20210630_def.xml EX-101.DEF 255826
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20210630_lab.xml EX-101.LAB 238214
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20210630_pre.xml EX-101.PRE 275299
14 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20210630_10q_htm.xml XML 537355
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 211163442
SIC: 2834 Pharmaceutical Preparations